
Evotec SE American Depositary Shares
EVODividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 22, 2019 | $0.07 | 2019-01-11 | 2019-01-14 |
| December 20, 2018 | $0.05 | 2018-12-12 | 2018-12-13 |
| November 19, 2018 | $0.05 | 2018-11-08 | 2018-11-12 |
| October 18, 2018 | $0.05 | 2018-10-10 | 2018-10-11 |
| September 21, 2018 | $0.05 | 2018-09-13 | 2018-09-14 |
Dividends Summary
- Evotec SE American Depositary Shares has issued 126 dividend payments over the past 11 years
- The most recent dividend was paid 2524 days ago, on January 22, 2019
- The highest dividend payed out to investors during this period was $0.07 per share
- The average dividend paid during this period was $0.06 per share.
Company News
MUVON Therapeutics announced positive Phase 2 clinical trial results for a novel muscle precursor cell therapy treating stress urinary incontinence, demonstrating high statistical significance and an 87% responder rate. The company also appointed Dr. Christine Günther as Chief Technology Officer to advance their regenerative medicine platform.
Kazia Therapeutics reported a patient with stage IV triple-negative breast cancer achieved an initial immune-complete response when treated with paxalisib combined with pembrolizumab and standard chemotherapy, showing a profound radiologic response in a highly aggressive cancer subtype.
Gambling may already seem to be everywhere, but the rollout of legal online action hasn't happened yet in California, Texas or Florida.
Evotec (EVO) signs a collaboration agreement with Janssen, a wholly owned subsidiary of J&J, for discovering novel drugs in the field of protein homeostasis. Shares down.



